Verge
Verge HealthTech Fund II
An early-stage healthtech Venture Fund composed of experienced investors and former entrepreneurs in the industry. The Team leverages a multidisciplinary, specialist and operator mindset to invest in and build best-in-class healthtech businesses that have already impacted over 53 million lives through 49 portfolio companies. Investing in Seed and Series A healthtech startups. Geo-agnostic, but indicative focus on companies founded in Asia and Europe with potential regional or global solutions to healthcare challenges, particularly in the developing world.
LP Base
Impact investors, family offices, strategic corporates, HNW individuals
Impact Summary
Impact Governance
🗹 Vision/mission statement with impact elements
🗹 ESG/Impact policies in place
Impact Strategy
🗹 Impact/ESG strategy integrated with investment strategy
🗹 Portfolio companies tackle affordability/accessibility issues
Impact Track Record
🗹 Team with Impact Experience
[N/A] Existing impact LPs
Reporting
🗹 Tracking impact KPIs/impact report available
Fundraising Details
Asset Class
VC Fund
Targeted Fund Size
USD 50 million
Close Date
Q4 2023
Impact theme
Healthcare
Geography
Global